Ramadan Fasting in Patients With Corticotrope Deficiency Treated Either by Hydrocortisone or by Prednisolone
Status:
Completed
Trial end date:
2018-07-25
Target enrollment:
Participant gender:
Summary
Selected patients will be randomised to either hydrocortisone or prednisolone. Each treatment
period is of 14 days. Abnormal clinical symptoms, blood glucose and quality of life will be
monitored.